Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04116047
Title CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC) (CompARE)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Birmingham
Indications

tongue squamous cell carcinoma

oropharynx cancer

tonsil squamous cell carcinoma

Therapies

Cisplatin

Cisplatin + Durvalumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.